Logo image of ARL

AMERICAN REALTY INVESTORS IN (ARL) Stock Fundamental Analysis

NYSE:ARL - New York Stock Exchange, Inc. - US0291741090 - Common Stock - Currency: USD

14.46  +0.2 (+1.4%)

Fundamental Rating

2

Overall ARL gets a fundamental rating of 2 out of 10. We evaluated ARL against 64 industry peers in the Real Estate Management & Development industry. ARL scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. ARL does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

ARL had negative earnings in the past year.
ARL had a negative operating cash flow in the past year.
ARL had positive earnings in 4 of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: ARL reported negative operating cash flow in multiple years.
ARL Yearly Net Income VS EBIT VS OCF VS FCFARL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M

1.2 Ratios

With a Return On Assets value of -1.29%, ARL perfoms like the industry average, outperforming 48.44% of the companies in the same industry.
ARL has a Return On Equity of -2.23%. This is comparable to the rest of the industry: ARL outperforms 53.13% of its industry peers.
Industry RankSector Rank
ROA -1.29%
ROE -2.23%
ROIC N/A
ROA(3y)10.05%
ROA(5y)6.32%
ROE(3y)19.68%
ROE(5y)12.84%
ROIC(3y)N/A
ROIC(5y)N/A
ARL Yearly ROA, ROE, ROICARL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

1.3 Margins

Looking at the Gross Margin, with a value of 44.32%, ARL is in the better half of the industry, outperforming 75.00% of the companies in the same industry.
ARL's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for ARL so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 44.32%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.35%
GM growth 5Y-1.62%
ARL Yearly Profit, Operating, Gross MarginsARL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 400 600 800

More info and screens

4

2. Health

2.1 Basic Checks

ARL does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ARL remains at a similar level compared to 1 year ago.
Compared to 5 years ago, ARL has more shares outstanding
The debt/assets ratio for ARL is higher compared to a year ago.
ARL Yearly Shares OutstandingARL Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
ARL Yearly Total Debt VS Total AssetsARL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

Based on the Altman-Z score of 1.17, we must say that ARL is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of ARL (1.17) is comparable to the rest of the industry.
ARL has a Debt/Equity ratio of 0.33. This is a healthy value indicating a solid balance between debt and equity.
ARL has a Debt to Equity ratio (0.33) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.33
Debt/FCF N/A
Altman-Z 1.17
ROIC/WACCN/A
WACC6.97%
ARL Yearly LT Debt VS Equity VS FCFARL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M 600M 800M 1B

2.3 Liquidity

ARL has a Current Ratio of 4.03. This indicates that ARL is financially healthy and has no problem in meeting its short term obligations.
ARL has a Current ratio of 4.03. This is in the better half of the industry: ARL outperforms 79.69% of its industry peers.
A Quick Ratio of 4.03 indicates that ARL has no problem at all paying its short term obligations.
ARL has a better Quick ratio (4.03) than 84.38% of its industry peers.
Industry RankSector Rank
Current Ratio 4.03
Quick Ratio 4.03
ARL Yearly Current Assets VS Current LiabilitesARL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

More info and screens

0

3. Growth

3.1 Past

ARL shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -600.06%.
The Revenue has decreased by -6.36% in the past year.
The Revenue has been decreasing by -0.29% on average over the past years.
EPS 1Y (TTM)-600.06%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%69.37%
Revenue 1Y (TTM)-6.36%
Revenue growth 3Y4.05%
Revenue growth 5Y-0.29%
Sales Q2Q%0.92%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ARL Yearly Revenue VS EstimatesARL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

ARL reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ARL Price Earnings VS Forward Price EarningsARL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as ARL.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 66.77
ARL Per share dataARL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ARL!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

AMERICAN REALTY INVESTORS IN

NYSE:ARL (8/20/2025, 8:04:00 PM)

14.46

+0.2 (+1.4%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)08-06 2025-08-06
Earnings (Next)11-05 2025-11-05
Inst Owners3.15%
Inst Owner Change-9.62%
Ins Owners0.66%
Ins Owner Change0%
Market Cap233.53M
Analysts0
Price TargetN/A
Short Float %1.56%
Short Ratio5.26
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 4.92
P/FCF N/A
P/OCF N/A
P/B 0.39
P/tB 0.39
EV/EBITDA 66.77
EPS(TTM)-0.84
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-5.5
FCFYN/A
OCF(TTM)-0.63
OCFYN/A
SpS2.94
BVpS37.46
TBVpS37.46
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.29%
ROE -2.23%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 44.32%
FCFM N/A
ROA(3y)10.05%
ROA(5y)6.32%
ROE(3y)19.68%
ROE(5y)12.84%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.35%
GM growth 5Y-1.62%
F-Score3
Asset Turnover0.05
Health
Industry RankSector Rank
Debt/Equity 0.33
Debt/FCF N/A
Debt/EBITDA 31.95
Cap/Depr 642.11%
Cap/Sales 165.84%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.03
Quick Ratio 4.03
Altman-Z 1.17
F-Score3
WACC6.97%
ROIC/WACCN/A
Cap/Depr(3y)243.84%
Cap/Depr(5y)175.89%
Cap/Sales(3y)69.61%
Cap/Sales(5y)51.54%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-600.06%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%69.37%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-6.36%
Revenue growth 3Y4.05%
Revenue growth 5Y-0.29%
Sales Q2Q%0.92%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y38.84%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-54.21%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y74.32%
OCF growth 3YN/A
OCF growth 5YN/A